eculizumab
Soliris is approved for inpatient use for atypical hemolytic uremic syndrome ONLY.
Excluded to outpatient use for all indications other than aHUS
Soliris is approved for inpatient use for atypical hemolytic uremic syndrome ONLY.
Excluded to outpatient use for all indications other than aHUS